6th World Congress on Leishmaniasis
16 May
Parallel Session
The Present and future of VL treatment
Chair: Fabiana Alves, DNDi, Geneva, Switzerland
Co-chair: Ahmed Musa, Institute of Endemic Diseases, University Khartoum, Sudan
| Treatment of VL: the African case Robert Kimutai, DNDi, Nairobi, Kenya |
| Current knowledge and needs for VL treatment in Brazil Gustavo Romero, Universidad de Brasilia, Brazil |
| New insights into the exposure-response relationships for miltefosine in the treatment for VL Thomas Dorlo, The Netherlands Cancer Institute, Amsterdam, Netherlands |
| Perspectives for improved treatments on VL Fabiana Alves, DNDi, Geneva, Switzerland |
PKDL
Chair: Ed Zijlstra, DNDi, Geneva, Switzerland
Co-chair: Shyam Sundar, Varanasi University, India
| PKDL an overview of clinical aspects Ahmed Musa, Institut of Endemic Diseases, University of Khartoum, Sudan |
| Special forms of PKDL Venkatesh Ramesh, Safdarjung Hospital, New Delhi, India |
| Advances in understanding of immunobiology of PKDL Poonam Salotra, Indian Council of Medical Research, New Delhi, India |
| PKDL insights in transmission Dinesh Monda, ICDDRB, Dhaka, Bangladesh |
Oral Communications Sessions
Clinical and experimental therapy in CL and VL
| Cohort observational study to estimate the proportion of post Kala-azar dermal leishmaniasis (PKDL) with at least two years follow up after treatment with three new treatment regiments in VL endemic districts of Bihar Goyal V, Rabi Das VN, Pandey K, Alves F, Rijal S, Das P, Alvar J |
| Safety of available treatments for visceral leishmaniasis in Brazil: Results from the LV Brasil Trial Rode J, Costa DL, Costa CHN, de Almeida RP, de Melo EV, de Carvalho SFG, Rabello A, de Carvalho AL, Sousa AQ, Leite RD, Lima SS, Amaral TA, Alves F, Romero GAS |
| Phase II randomized clinical trial of the efficacy and safety of Ambisome® in combination with sodium stibogluconate or miltefosine versus milterfosine monotherapy for African visceral leishmaniasis Wasunna M, Njenga S, Balasegaram M, Alexander N, Omollo R, Edwards T, Dorlo T, Musa B, Ali MHS, Yassein M, Kirigi G, Juma R, Kip AE, Schoone G, Hailu A, Olobo J, Ellis S, Kimutai R, Wells S, Khalil E, Strub–Wourgaft N, Alves F, Musa A |
Satellite Symposium
Landscape of Spanish research in leishmaniasis
Supported by Marca España and sponsered by RICET and SEMTSI
Chair: Luis Rivas, CSIC
Co-chair: Jorge Alvar, DNDi, Geneva, Switzerland
| Applied research at the WHO Collaborating Centre of Leishmaniasis Javier Moreno, ISCII |
| Basic research at the CSIC Dolores González Pacanowska, IPB-CSIC |
| Clinical research & international cooperation Nines Lima, MSF, Spain |
| Canine leishmaniasis research at university Guadalupe Miró, ICM |
